Uproleselan

Drug identity checked against registry records

Also recorded as GMI-1271

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Study to Evaluate the Efficacy of Uproleselan in Combination With Chemotherapy in Chinese Patients With R/R AMLNCT05054543APLMPhase 3Terminated2024-08-22Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.